DEXLEVO
12.5.2022 04:31:14 CEST | Business Wire | Press release
The aesthetic and medical device company DEXLEVO attended the 20th AMWC (Aesthetic & Anti-aging Medicine World Congress) held in Monaco and explained its products to the visitors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220502005974/en/
The world's first fully liquid PCL (polycaprolactone) injectable, GOURI developed by DEXLEVO, an aesthetic and medical device company, was the first in Asia to be chosen as Best Injectable in the category at the 20th AMWC (Aesthetic & Anti-aging Medicine World Congress) held in Monaco from March 31 to April 2, 2022.
AMWC is one of the world's most prestigious aesthetic and anti-aging congresses. More than 20,000 visitors from more than 200 countries worldwide, including dermatologists, attend the event every year to share the latest trends in aesthetic and anti-aging products and industry trends.
DEXLEVO launched GOURI, the world's first fully liquid PCL injectable, at the AMWC in 2021. Attending AMWC for the second year, it won the Best Injectable award for the first time as an Asian company at the AMWC Awards, having its unique technology and products recognized on the world stage. For the AMWC Awards, the AMWC Committee reviews and chooses the candidate products, judged by votes from dermatologists and industry workers around the world. At this year's review, DEXLEVO was nominated alongside prominent global beauty companies such as Allergan, Merz, Fillmed, and Aptos, proving its competence in the global market.
More than 150 doctors and companies visited DEXLEVO's booth and showed great interest in GOURI, which provides a fundamental solution to anti-aging.
Under the theme of "1st Liquid PCL-What, When, Why?", Mexican dermatologist Dr. Arturo Vela said, "The beauty market now wants naturalness. DEXLEVO's GOURI is the world's first fully liquid PCL injectable and the safest anti-aging product that meets consumer needs." Croatian dermatologist Dr. Dinko Kaliterna gave a treatment lecture at the congress under the theme "Skin Rejuvenation with Liquid PCL," saying, "GOURI is safer than competing products and its treatment is very convenient. Also, patient’s satisfaction with the procedure is high due to the natural collagen regeneration effect."
An official from DEXLEVO said, "As the trend in the beauty market changes, more companies are showing interest compared to last year's AMWC. Since the global market is showing increasing interest in GOURI, we plan to support marketing to become a leader in anti-aging products."
DEXLEVO's GOURI is the world's first fully liquid type PCL injectable of polycaprolactone (PCL), a biodegradable polymer material, that spreads naturally throughout the face and around the eyes when injected into the skin, forming a three-dimensional matrix and causing collagen production.
With the launch of AMWC in September 2021, DEXLEVO is selling and contracting GOURI in more than 40 countries and will participate as a platinum sponsor in IMCAS 2022, to be held in Paris in June this year, to accelerate marketing activities and expand the global market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005974/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union9.3.2026 22:00:00 CET | Press release
Operio Group has signed a distribution agreement with Schaefer Technologies, a manufacturer of semi-automatic encapsulation equipment. Operio Group, a holding company building a global group of brands serving the solid dose manufacturing industry, will be the official distributor of Schaefer Technologies’ products in the United Kingdom and the European Union. Schaefer Technologies develops semi-automatic capsule filling systems, including equipment that produces banded capsules for liquid and pellet formulations used by nutraceutical and pharmaceutical manufacturers. Leadership from both companies worked together to establish the agreement, including Kevin Schaefer, CEO of Schaefer Technologies Inc., and Alastair Sanderson, Chief Business Development Officer at Operio Group. “Schaefer Technologies is looking forward to our new relationship with Operio Group,” said Schaefer. “Their understanding of the pharmaceutical equipment market makes them a strong partner as we combine our experti
Kinaxis Goes All-In on Innovation at Upcoming Kinexions in Las Vegas9.3.2026 19:00:00 CET | Press release
Annual customer conference will bring together global supply chain leaders to explore the latest trends, best practices and technologies in AI-powered planning, decision-making and agentic innovation Registration is officially open for Kinexions North America, the premier global supply chain orchestration conference hosted by Kinaxis® Inc. (TSX: KXS). Taking place June 1–3 in Las Vegas, Nevada, the event brings together supply chain leaders, innovators and practitioners from around the world to explore how organizations can leverage AI-driven strategies and technologies to connect data, people and decisions. After a year defined by market volatility, geopolitical risk and disruption, this year’s conference will focus on how intelligent supply chain orchestration enables organizations to move beyond reactive planning to building true enterprise adaptability. The program promises to be the most immersive and future-forward Kinexions yet, with renowned author, entrepreneur and innovation
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice9.3.2026 17:00:00 CET | Press release
InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The announcement comes as healthcare leaders gather for the 2026 HIMSS Global Health Conference & Exhibition. In this role, Dr. Ferris will leverage his comprehensive view of the industry to help drive the clinical and strategic direction of the company’s healthcare solutions worldwide. Drawing on his vast experience, he will serve as a strategic advisor to global health systems and governments, engineer targeted technology solutions based on real-world executive needs, advance his academic research on health data architecture and lead public discourse on the intersection of AI and care delivery. Dr. Ferris brings a unique global perspective to InterSystems that is virtually unmatched in healthcare. His career spans 30 years as a practicing primary care physician, executive leadership at pr
Radial Selects Riskified to Power Payment Fraud and Refund/Return Protection for Merchant Client Portfolio9.3.2026 15:00:00 CET | Press release
The partnership brings Riskified’s AI-powered platform for payment fraud, refund claim, and return abuse protection to Radial’s global network of merchants Riskified (NYSE: RSKD), a leader in ecommerce fraud and risk intelligence, today announced a strategic partnership with Radial, a leading 3PL set to become Paxon later this year. Radial will integrate with Riskified’s AI-powered platform to help its merchants approve more legitimate orders and reduce losses from payment fraud, including many merchants that use Shopify as their ecommerce platform. Radial supports many of the world’s most recognized retail brands with a global ecommerce fulfillment network of more than 20 centers across North America, helping merchants deliver orders quickly and cost effectively. By bringing Riskified’s AI-powered fraud decisioning into its commerce ecosystem, Radial gives merchants the surgical ability to calibrate the checkout experience according to risk—without slowing fulfillment. This also suppo
Boomi Activates Data for the Enterprise9.3.2026 14:00:00 CET | Press release
New platform innovations activate contextual data to power production-scale enterprise AI, with a new European platform instance for localized control Boomi™, the data activation company, today announced new capabilities within the Boomi Enterprise Platform. Data activation brings data to life across systems and processes, delivering it with the right context and timing to power everything from AI to BI. The Boomi Enterprise Platform, the foundation that puts data in motion, now adds new semantic context to help AI agents operate on grounded business realities, expands governed SAP data movement with change data capture, enhances transparency and oversight across agentic workflows, and introduces a dedicated European platform instance for localized data control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260309682526/en/ Boomi Activates Data for the Enterprise “Last year, Boomi helped enterprises move from experimentatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom